RegulationPrimary source

CVS Agrees to Pay $315M for Illegally Filling Unlawful Opioid Prescriptions and for Submitting False Claims to the Federal Government

HONOLULU – United States Attorney Ken Sorenson announced that CVS Pharmacy Inc., a Rhode Island-based pharmacy chain, and its related corporate entities (collectively, CVS) have agreed to pay $315 million to resolve allegations that, from October 17, 2013 through December 2, 2025, CVS illegally filled prescriptions for opioids and other controlled substances in violation of the Controlled Substances Act (CSA),...

What happened

HONOLULU – United States Attorney Ken Sorenson announced that CVS Pharmacy Inc., a Rhode Island-based pharmacy chain, and its related corporate entities (collectively, CVS) have agreed to pay $315 million to resolve allegations that, from October 17, 2013 through December 2, 2025, CVS illegally filled prescriptions for opioids and other controlled substances in violation of the Controlled Substances Act (CSA),...

Why it matters

The development may change operating conditions or market expectations around Regulation. Further confirmation and measurable outcomes matter.

Affected entities

View evidence

1 reports · 1 original report · 1 independent

  1. U.S. Department of JusticePrimary source · Supports · EN · 100%
    CVS Agrees to Pay $315M for Illegally Filling Unlawful Opioid Prescriptions and for Submitting False Claims to the Federal Government ↗

Claims

  • CVS Agrees to Pay $315M for Illegally Filling Unlawful Opioid Prescriptions and for Submitting False Claims to the Federal Government Observed

Conflicts

No material conflict detected in the available evidence.

Timeline

  1. First reported

Market move following event

Market reaction is not yet available for this asset and time window.

Score explanation

Confidence · formula confidence-2.1.0
Source trust97
Independent corroboration51
Primary evidence100
Claim consistency82
Extraction confidence82
Attribution quality90
Impact · formula impact-2.1.0
Event magnitude45
Market relevance88
Entity significance42
Market breadth45
Novelty68
Urgency52
capital magnitude100
Ranking · formula rank-1.0.0
Confidence factor0.9235
Freshness factor0.9025
Breaking bonus0